Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Arcus Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 185 | 1 | 172 | −12 |
| Shares | 52.8M | 2.52K | 52.9M | +9.06K (0.0%) |
| Value | $1.01B | $48.1K | $997.7M | −$11.6M (−1.1%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Arcus Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 547,474 | $10.3M | 0.29% |
| D. E. Shaw & Co., Inc. | 67,542 | $1.28M | 0.00% |
| Winton Group Ltd | 57,265 | $1.08M | 0.08% |
| Dark Forest Capital Management LP | 35,590 | $671.9K | 0.11% |
| Jump Financial, LLC | 32,190 | $607.7K | 0.02% |
| Capital Fund Management S.A. | 13,576 | $256.3K | 0.00% |
| Marex Group plc | 13,500 | $254.9K | 0.01% |
| Diversified Trust Co | 12,078 | $228.0K | 0.01% |
| LPL Financial LLC | 10,063 | $190.0K | 0.00% |
| Anfield Capital Management, LLC | 8,041 | $151.8K | 0.07% |
| Headlands Technologies LLC | 3,139 | $59.3K | 0.01% |
| Steward Partners Investment Advisory, LLC | 2,000 | $37.8K | 0.00% |
| Spartan Fund Management Inc. | 2,000 | $37.8K | 0.08% |
| Pacer Advisors, Inc. | 1,579 | $29.8K | 0.00% |
| Continuum Advisory, LLC | 33 | $533 | 0.00% |
| Umb Bank N A | 22 | $415 | 0.00% |
| Riggs Asset Managment Co. Inc. | 19 | $359 | 0.00% |
| Rothschild Investment LLC | 10 | $189 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 10 | $188 | 0.00% |
Sold out (31)
Institutions that held Arcus Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (1)
Institutions that held Arcus Biosciences, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Coppell Advisory Solutions LLC | 2,519 | $48.1K |